Literature DB >> 18799580

Induction of cellular stress overcomes the requirement of herpes simplex virus type 1 for immediate-early protein ICP0 and reactivates expression from quiescent viral genomes.

Chris M Preston1, Mary Jane Nicholl.   

Abstract

Herpes simplex virus type 1 (HSV-1) mutants impaired in the activities of the structural protein VP16 and the immediate-early (IE) proteins ICP0 and ICP4 establish a quiescent infection in human fibroblasts, with most cells retaining an inactive, repressed viral genome for sustained periods in culture. To date, the quiescent state has been considered stable, since it has been reversed only by provision of herpesviral proteins, such as ICP0, not by alteration of the cell physiological state. We report that the interaction of HSV-1 with human fibroblasts can be altered significantly by transient treatment of cultures with sodium arsenite, an inducer of heat shock and oxidative stress, or gramicidin D, a toxin that selectively permeabilizes cell membranes, prior to infection. These regimens stimulated gene expression from IE-deficient HSV-1 mutants in a promoter sequence-independent manner and also overcame the replication defect of ICP0-null mutants. Reactivation of gene expression from quiescent HSV-1 genomes and the resumption of virus replication were observed following addition of arsenite or gramicidin D to cultures. Both agents induced reorganization of nuclear domain 10 structures, the sites of quiescent genomes, but appeared to do so through different mechanisms. The results demonstrate that the physiological state of the cell is important in determining the outcome of infection with IE-deficient HSV-1 and show novel methods for reactivating quiescent HSV-1 in fibroblasts with a high efficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799580      PMCID: PMC2583663          DOI: 10.1128/JVI.01273-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.

Authors:  C L Addison; M Hitt; D Kunsken; F L Graham
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

2.  Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis.

Authors:  C M Preston; M J Nicholl
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

4.  Herpes simplex virus type 1 immediate early gene expression is stimulated by inhibition of protein synthesis.

Authors:  C M Preston; A Rinaldi; M J Nicholl
Journal:  J Gen Virol       Date:  1998-01       Impact factor: 3.891

5.  Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression.

Authors:  Ryan T Saffert; Robert F Kalejta
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Mechanisms of herpes simplex virus type 1 reactivation.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Interaction of the viral activator protein ICP4 with TFIID through TAF250.

Authors:  M J Carrozza; N A DeLuca
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1.

Authors:  F Yao; P A Schaffer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants.

Authors:  D R Jamieson; L H Robinson; J I Daksis; M J Nicholl; C M Preston
Journal:  J Gen Virol       Date:  1995-06       Impact factor: 3.891

10.  Impact of the interaction between herpes simplex virus type 1 regulatory protein ICP0 and ubiquitin-specific protease USP7 on activation of adeno-associated virus type 2 rep gene expression.

Authors:  Marie-Claude Geoffroy; Gilliane Chadeuf; Anne Orr; Anna Salvetti; Roger D Everett
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more
  11 in total

1.  Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Authors:  Michael W Ferenczy; Neal A DeLuca
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

2.  A comparative study of stress-mediated immunological functions with the adjuvanticity of alum.

Authors:  Yufei Wang; Durdana Rahman; Thomas Lehner
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

3.  Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1.

Authors:  Michael W Ferenczy; Daniel J Ranayhossaini; Neal A Deluca
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

4.  Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency In Vitro.

Authors:  Terri G Edwards; David C Bloom
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  DNA damage promotes herpes simplex virus-1 protein expression in a neuroblastoma cell line.

Authors:  Ketna Volcy; Nigel W Fraser
Journal:  J Neurovirol       Date:  2013-01-26       Impact factor: 2.643

6.  Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes.

Authors:  Roger D Everett; Marie-Laure Parsy; Anne Orr
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

7.  Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection.

Authors:  Igor Jurak; Michael Hackenberg; Ju Youn Kim; Jean M Pesola; Roger D Everett; Chris M Preston; Angus C Wilson; Donald M Coen
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

8.  A DNA Vaccine Formulated with Chemical Adjuvant Provides Partial Protection against Bovine Herpes Virus Infection in Cattle.

Authors:  Valeria Quattrocchi; Ivana Soria; Cecilia Ana Langellotti; Victoria Gnazzo; Mariela Gammella; Dadin P Moore; Patricia I Zamorano
Journal:  Front Immunol       Date:  2017-01-25       Impact factor: 7.561

9.  Timing Is Everything.

Authors:  Luis M Schang
Journal:  MBio       Date:  2018-01-02       Impact factor: 7.867

Review 10.  Disease progression mediated by egr-1 associated signaling in response to oxidative stress.

Authors:  Judith-Irina Pagel; Elisabeth Deindl
Journal:  Int J Mol Sci       Date:  2012-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.